Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Expands Veterinary Assay Pact with British Lab

NEW YORK (GenomeWeb News) – Qiagen today said that it has expanded its partnership with the UK's Veterinary Laboratories Agency to sell three new PCR-based tests for detecting widespread bacterial diseases in horses.

Qiagen has exclusive rights to market the tests, which have been developed and validated in collaboration with the VLA, for Streptococcus equi, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Financial terms of the new agreement were not disclosed.

Qiagen and the VLA started their collaborative efforts in 2006. Since then, Qiagen has launched several PCR-based assays for infectious livestock diseases, including a test for the bovine viral diarrhea virus "which played an important role in the corresponding national eradication program in Switzerland," Qiagen said in a statement.

The firm also noted that the new assays will complement its line of cador molecular tests for animal diseases. Outside of the US, Qiagen sells a molecular assay for Taylorella equigenitalis, which is the cause of contagious equine metritis. Under the new agreement with the VLA, Qiagen said that it will adapt this test to cover additional bacteria that cause infertility, including Klebsiella pneumoniae and Pseudomonas aeruginosa.

"Molecular technologies are already the first choice in veterinary testing for many costly viral diseases such as bovine viral diarrhea or bluetongue," Simone Gauch, Qiagen's senior global marketing director for applied testing, said in the statement. "We now also are experiencing a growing demand for modern molecular technologies enabling the fast and reliable detection of bacterial infections."

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.